Qiyu Tang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy.
Journal: Med (New York, N.Y.)
Published: May 13, 2025
Clinical benefits of immune checkpoint inhibitors for malignant peripheral nerve sheath tumors with NF2 mutation: a case report.
Journal: Frontiers in immunology
Published: March 19, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapies.
Journal: Med (New York, N.Y.)
Published: February 03, 2025
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasis.
Journal: Brain : a journal of neurology
Published: May 14, 2024
The global landscape of clinical trials and drug discovery for brain metastasis.
Journal: Journal of translational medicine
Published: May 10, 2024
Accelerating the establishment of management systems for compassionate use in China.
Journal: Drug discovery today
Published: May 06, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 23, 2024
Exosome-based anticancer vaccines: From Bench to bedside.
Journal: Cancer letters
Published: March 14, 2024
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrier.
Journal: Acta pharmaceutica Sinica. B
Published: October 20, 2023
The current status and future of ADC therapy for small cell Lung Cancer: a promising approach.
Journal: Journal of translational medicine
Published: August 23, 2023
Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: November 08, 2022
Breaking boundaries: Current progress of anticancer NK cell-based drug development.
Journal: Drug discovery today
Published: October 12, 2022
Last Updated: 09/26/2026